Literature DB >> 4160811

Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--third investigation: the effect of an initial streptomycin supplement.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4160811     DOI： 10.1016/s0041-3879(66)80060-0

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  4 in total

1.  Intermittent isoniazid and thiacetazone in childhood tuberculosis with reference to clinical intolerance.

Authors:  B Bhandari; A M Jain; S K Kulshrestha; S Mehta
Journal:  Indian J Pediatr       Date:  1972-01       Impact factor: 1.967

2.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  Quality of reporting of outcomes in phase III studies of pulmonary tuberculosis: a systematic review.

Authors:  Laura Jayne Bonnett; Gie Ken-Dror; Geraint Rhys Davies
Journal:  Trials       Date:  2018-02-21       Impact factor: 2.279

4.  The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.

Authors:  P R Donald; D P Parkin; H I Seifart; H S Schaaf; P D van Helden; C J Werely; F A Sirgel; A Venter; J S Maritz
Journal:  Eur J Clin Pharmacol       Date:  2007-05-16       Impact factor: 3.064
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.